BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20150329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20151025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20171029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20161028T080000
DTEND;TZID=Europe/London:20161028T170000
DTSTAMP:20260417T152112
CREATED:20171013T123220Z
LAST-MODIFIED:20171013T123220Z
UID:17632-1477641600-1477674000@staging.medilinkmidlands.com
SUMMARY:Life Science and BioScience Business Opportunities in India
DESCRIPTION:Please save the date for Leicester and Leicestershire’s Gateway to India event\, an international trade event being held as part of the Leicester Business Festival. \nGateway to India is sponsored by Santander and supported by the Department for International Trade.  This one day event promotes better links between the Midlands and India\, and will include industry expert-led workshop opportunities. \nThe Indian biotechnology sector is anticipated to grow to £60 billion by 2025. The pharmaceutical sector is estimated to grow to £27 billion by 2020 and is dominated by generic drugs. Growth is projected due to pharmaceutical outsourcing and investments by multinational companies. \nOpportunities in the sector include:\n– Co-development\n– Contract research in drug discovery and development \nOncology\, diabetes\, regenerative medicine\, and vaccines are some of the therapeutic growth areas for R&D collaborations\, and there is a growing demand for regulatory stability\, licensing partners for innovative research\, and contract manufacturing following global norms. Licensing arrangements through R&D investments in the biopharma sectors generate significant income. \nJoin the British Deputy High Commissioner for Gujarat and senior UK Trade advisers to find out more about opportunities for Midlands businesses in India. \nTo find out more information or register your free place\, please click here.
URL:https://staging.medilinkmidlands.com/event/life-science-and-bioscience-business-opportunities-in-india/
LOCATION:Curve Theatre\, 60 Rutland Street\, Leicester\, LE1 1SB
END:VEVENT
END:VCALENDAR